Best fit deal puts Smiths Medical up with the big boys
This article was originally published in Clinica
Executive Summary
Last week, Smiths Medical announced that it is to pay $925m to acquire US safety device firm Medex. The new addition will significantly raise the London-based hospital products company's profile, not only in the medical device industry, but also within Smiths Group, the aerospace and engineering firm that it is part of. Lawrence Kinet, Smiths Medical's managing director, met Eleanor Malone a few days after the acquisition was announced
You may also be interested in...
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.